Robert Bosch GmbH, Germany

Time frame: 1 December 2022 - 30 November 2023

Profile

The positions in the table below reflect the Robert Bosch GmbH's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where Robert Bosch GmbH is listed.

Position by research output Share

Global Germany
Overall 2811 121
Corporate 198 22

Position by research output Share in subject areas

Global Germany
Chemistry 2432
Health sciences 2691 114
Physical sciences 1546 78

Research

Overall research output

Count Share
Overall 10 1.15

Overall Count and Share for 'Robert Bosch GmbH' based on the 12-month time frame mentioned above.

View all articles

Research outputs by subject area

Subject Count Share
Chemistry 2 0.04
Health sciences 2 0.18
Physical sciences 7 0.94

Note: Articles may be assigned to more than one subject area. Hover over the donut graph to view the Share for each subject.

Share output for the past 5 years

Compare with other institutions

Nature Strategy Reports

Identify research insights to guide research strategy and grow your impact with our Nature Strategy reports.

  1. Actionable insights into research performance.

  2. Detailed analysis of strengths and weaknesses.

  3. Covers all major disciplines and regions of the world.

Nature Navigator

Data-driven insights for informed research strategy decisions with AI summarisation technology.

  1. Track trends, summarise articles effortlessly.

  2. Spark serendipitous discoveries.

  3. Uncover collaboration opportunities.

Collaboration

International vs domestic collaboration by Share

Type Percentage
International (69 institutions) 67.8%
Domestic (13 institutions) 32.2%

Note: Hover over the graph to view the percentage of collaboration.

Top 5 domestic collaborators with Robert Bosch GmbH by Share

Collaborating institutions

Share

Top 5 international collaborators with Robert Bosch GmbH by Share

Collaborating institutions

Share

  • Advertisement

Latest supplement

Nature Index 2024 Health Sciences

More money is being spent on medical R&D than ever before, but with few new drugs to show for it. The race is on to find technological solutions that will speed up drug development and deliver better clinical outcomes. Nature Index Health Sciences 2024 highlights the people and projects that are bringing fresh perspectives to some of the most complex challenges in medicine and provides an in-depth look at how one country – the United States – is dominating the field.

Nature Index 2024 Health Sciences

Relationships